Cormark Has Bearish Forecast for Cresco Labs FY2026 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBF - Free Report) - Stock analysts at Cormark decreased their FY2026 earnings per share (EPS) estimates for shares of Cresco Labs in a note issued to investors on Tuesday, June 3rd. Cormark analyst J. Pytlak now forecasts that the company will post earnings per share of $0.00 for the year, down from their prior forecast of $0.01. Cormark has a "Moderate Buy" rating on the stock. The consensus estimate for Cresco Labs' current full-year earnings is ($0.20) per share.

Separately, Canaccord Genuity Group downgraded shares of Cresco Labs from a "strong-buy" rating to a "moderate buy" rating in a research report on Tuesday. Two analysts have rated the stock with a hold rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy".

Cresco Labs Stock Performance

Shares of Cresco Labs stock traded up $0.02 during trading hours on Wednesday, reaching $0.53. The company's stock had a trading volume of 768,089 shares, compared to its average volume of 655,135. Cresco Labs has a one year low of $0.49 and a one year high of $2.05. The company's 50 day simple moving average is $0.69 and its 200 day simple moving average is $0.84. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.39 and a current ratio of 1.97. The stock has a market cap of $260.24 million, a P/E ratio of -2.65 and a beta of 1.73.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last released its quarterly earnings data on Friday, May 30th. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.01). Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. The business had revenue of $165.76 million during the quarter, compared to analyst estimates of $164.37 million.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.